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1. Introduction
Magnetoencephalography (MEG) is a technique which detects weak magnetic fields from
above the surface of the head produced by electrical activity within the brain (Hämäläinen
et al., 1993). It is non-invasive, acoustically silent and able to measure a direct correlate of
neuronal activity with sub-millisecond resolution. The technique is therefore well suited to
clinical applications as it can readily be used in children and other populations who may
not tolerate more demanding procedures such as fMRI or PET. Clinical applications of MEG,
although currently limited, have developed in parallel with advances in hardware, software,
analysis tools and general understanding of the technique as a non-invasive measure of
biomagnetic neuronal activity. The goal of this review is to describe the advances made to
date regarding the clinical applications of the technique and the potential areas for expansion
and application in the future.
Although much MEG research has been conducted in clinical populations, helping to provide
an understanding of the pathology and manifestation of various categories of illness, it
generally remains a technique used in the research laboratory rather than as a routine
part of clinical evaluations. MEG is routinely used in research to investigate the dynamic
neuronal processes involved in the representation of sensory systems such as vision, audition,
somatosensation and movement. The technique is also readily applied to experiments
studying more cognitive processes such as language perception, memory encoding and
retrieval and higher level tasks. Non-invasive imaging of the human brain is potentially a very
useful diagnostic tool in the identification, prevention and treatment of numerous disease and
illnesses as it is able to study a range of cerebral functions.
The main clinical application of MEG remains in the pre-surgical evaluation of patients
suffering from epilepsy. In recent years, the technique has been applied to the study of a
much broader range of symptoms and pathologies, however this is almost exclusively in
the context of research on clinical populations rather than being a routinely used diagnostic
procedure. The aim of this chapter is not to provide an exhaustive review of all studies which
report the use of MEG scanning techniques on individuals from a clinical population. The
aim is to give an overview of how the clinical applications of the technique have developed
in parallel with purely methodological and empirical research applications and to highlight
steps which are necessary for the technique to be more readily applied to a wider range of
clinically relevant problems. The first part of this chapter gives on overview of the early uses
of MEG in the patient care and treatment plan of individuals suffering from epilepsy. Again,
rather than focusing on the many studies published in this area which provide evidence for
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the usefulness of MEG as a diagnostic tool, the chapter will focus on describing how the
use of MEG in the epilepsy field has continued to evolve and develop in conjunction with
the methodological and cognitive applications of the technique. In many ways, the use of
MEG in the epilepsy population represents a bench-mark for what may be possible in other
clinical populations. The chapter will then describe preliminary results from patient groups
suffering from a range of diseases including Parkinsonism, Alzheimer’s disease, cortical
lesions, and Autism. Themain theme of the chapter will be that it is essential that high-quality,
robust and rigorous research studies precede any advances towards using MEG as a clinically
useful tool and that these studies must be performed by multi-disciplinary research teams
combining methodological and technical expertise with clinicians willing to strive towards
faster, more objective and robust diagnostic methods. The chapter concludes that, although
currently the application of MEG as a diagnostic tool to many types of illness is premature, the
potential uses of MEG as a clinically accessible technique are vast. Due to large steps forward
in the understanding of MEG signals and the proliferation of specific and flexible analysis
techniques, the effectiveness of MEG now extends far beyond that of epilepsy and the next
5-10 years could see MEG become a diagnostic tool for a great many conditions.
2. Epilepsy research
Epileptic seizures are caused by spontaneous and uncontrolled electrical activity within the
brain. Although there are many different sub-types of epilepsy, many of these manifest
themselves as spontaneous, high-amplitude electrical activity and therefore are particularly
well suited to detection via MEG. There are a number of excellent reviews of the role of
MEG in the diagnosis and pre-surgical evaluation of epilepsy patients (for example da Silva,
2005; Knowlton, 2003; Tovar-Spinoza et al., 2008). As outlined in the introduction, the aim of
this chapter is not to exhaustively describe the evidence for the effectiveness of MEG in the
diagnosis of epilepsy, but to outline the progression of the analyses and methods used in the
study of epilepsy and to highlight where this has been successful.
2.1 Early epilepsy research
Initial studies utilising MEG to measure magnetic field distributions from epilepsy patients
treated the technique as a subtle variation on electroencepahlography (EEG). EEG has been a
widely used technique with which to categorise various types of epilepsy and to determine
the best course of treatment for a given pathology for many decades (Abbott & Schwab,
1948; Parker, 1947). EEG is still the most commonly used tool in hospitals to determine
the focus of an individuals epilepsy. Initially MEG was used in a similar way, with the
magnetic fields being analysed in much the same way as the EEG waveforms. The standard
method was to visualise the waveforms on the electrodes or sensors and describe the scalp
locations which showed slow, or spike-wave activity. Rose et al. (1987) used MEG, EEG
and electrocorticography to measure inter-ictal spikes from three young adults suffering from
epilepsy. It was found that MEG dipoles could be calculated from the scalp topography and a
simple dipole fitting algorithm localised these to the anterior-temporal lobe. This localisation
showed good concordance with the intra-operative electrode recordings from various surfaces
of the temporal lobe, whereas the mapping of EEG spikes showed a localisation either anterior
or posterior to the location identified by MEG. This was one of the first examples of a
case where the localisation of high-amplitude inter-ictal activity in MEG not only appeared
possible, but was also more closely related to the data collected by electrodes placed on the
cortical surface during neurosurgery than the localisation achieved via EEG.
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Following these early studies there were a number of validatory experiments which compared
the localisation capabilities of MEG to those of EEG and intra-operative recordings (for
example Knake et al., 2006; Rose et al., 1991). The consensus was that MEG provided a viable
alternative to the invasive procedure of electrocorticography for pre-surgical localisation of
epileptogenic zones and, due to the spatial smearing of electrical signals caused by the
conductivity of the dura and skull, MEG provided a potentially more reliable and accurate
signal than EEG on which to base the localisation of epileptiform activity (Nakasato et al.,
1994). The primary analysis tool for analysing these high-amplitude, transient bursts of
energy was the equivalent current dipole (ECD). Ebersole (1997) provides an introduction to
the concept and implementation of dipole models to epilepsy data, but the technique is simply
a fitting procedure in which an algorithm determines the location, orientation and strength
of a dipole which minimises the error between the observed field and the field topography
produced by the model. The head is assumed to be a sphere and the ECDs calculated are
typically considered valid if the correlation between the modelled and observed field patterns
is greater than 98% and have a physiologically realistic magnitude (Otsubo & Snead, 2001).
The field of epilepsy research using MEG then moved from simply identifying the irritative
zone (region of the brain which generates interictal epileptogenic discharges), to delineating
regions of eloquent cortex. The term eloquent cortex is used to define cortical locations that
if removed or damaged would result in a loss of sensory processing, linguistic ability or the
ability to make controlled movements. Many cases of epilepsy are concurrent with some form
of structural deficit, such as a tumour, an infarction or focal cortical dysplasia. It is these types
of cases that are particularly suitable for surgical re-section if the structural deficit is shown
by some other technique (typically EEG) to also form the epileptogenic zone. These regions
are often in or very close to language areas and the sensorimotor cortex. MEG thus became
a tool for not only lateralising and localising epileptogenic cortex by measuring spontaneous
magnetic fields when the patient was at rest, but also for measuring fields generated during a
task in order to allow the localisation of specific perceptual functions.
Primary sensory regions (for example, motor, somatosensory, auditory, visual) can be localised
in MEG with relative ease. The tasks are typically simple, the protocols are short and
the analyses often a straight-forward extension of the dipolar techniques used to localise
spontaneous spike activity. Hund et al. (1997) introduced a measure of surgical risk for
cortical lesions located adjacent to the motor cortex. They use the minimal distance between
the lesion and sensory and motor cortex as defined by MEG to calculate a functional risk
profile. Of the forty patients in the study, 11 patients with gliomas showed a high risk profile
and 6 of these individuals underwent non-operative treatment. Of the 28 patients with a low
functional risk profile, none showed any neurological deficit postoperatively. Ganslandt et al.
(1999) investigated 50 patients who had a tumour resected from around the motor cortex.
The sensorimotor cortex was defined in all patients using MEG in conjunction with dipolar
modelling techniques. The central sulcus was identified intra-operatively and this localisation
was comparedwith theMEG results with the two showing excellent concordance. The efficacy
of localising sensorimotor cortex via MEG has also been compared to electrocorticography
recordings. Roberts et al. (2000) compared the mapping of somatosensory motor cortex with
intra-operative cortical stimulation and found that the results were concordant in 90% of cases,
with a high level of concordance in 77% of cases. One of the reasons for the success of MEG
in being able to accurately identify the location of primary sensory areas such as primary
auditory, somatosensory, motor and visual cortex is the fact that these are well defined cortical
regions. From electrophysiological studies, the cytoarchitecture of these areas in the normal
population is known. Not only is the location of these primary cortices well established, but
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they represent relatively discrete processing modules. The other function most commonly
localised pre-surgically to reduce the risk of removing eloquent cortex is language processing.
However, the language network does not have a primary cortex of representation and is more
accurately described as a distributed neuronal network.
Simos et al. (1998) introduced a method via which language laterality could be determined
in MEG. Individuals were placed in the scanner and the tasks used were a word-matching
and a tone matching task. In each task, the portion of the response that was analysed
was after the onset evoked from primary sensory cortices which typically occurs between
80 and 150 ms. The latter portion of the response was analysed and ECDs were used to
compute an interhemispheric laterality index. A greater number of dipole solutions were
found in the left hemisphere in 87% of subjects in response to the word-matching task. This
study demonstrated that it was feasible to place an individual in the MEG scanner whilst
performing a language task and the event-related fields produced during this task could
be modelled using the now well established dipole techniques, and that the results could
reveal information regarding the underlying hemispheric dominance. This protocol was then
developed and optimised and the next step was to compare the ability of MEG to determine
language function with an independent, established technique.
The Intra-carotid Amobarbital Procedure (IAP) (Wada & Rasmussen, 2007) has been a
standard pre-operative diagnostic tool in epilepsy patients since its inception in the 1960’s.
The test involves injection of a barbiturate into one cerebral hemisphere in order to anesthetise
it. A language and memory task is then conducted in order to determine the language
capabilities of the non-injected hemisphere. The process is then repeated with the other
hemisphere injected. The scores from each of the two tests are then used to determine if
either cerebral hemisphere shows dominance for language or memory or if the result is a
bilateral representation of function. The results of the test are often used to confirm whether
or not a patient is suitable for surgical re-section. The procedure is sensitive to differences
in vasculature, has strict time constraints which limit the amount of testing possible and is
also associated with risk of morbidity. It is therefore desirable to replace this procedure with a
non-invasive alternative which is able to provide the same information regarding hemispheric
dominance for language function.
Breier et al. (1999) extended the initial implementation of the language lateralisation paradigm
in MEG described by Simos et al. (1998) and investigated concordance levels between the
IAP and MEG lateralisation metrics in 26 patients suffering from intractable epilepsy. The
results confirmed that there were high levels of agreement between the two metrics. This
template of performing non-invasive MEG tests of language dominance in parallel with IAP
tests (which patients were having regardless) in order to reach a conclusion regarding their
suitability for surgical re-section became widely used in order to provide mounting evidence
for the ability of MEG to be used as a pre-operative diagnostic tool. Papanicolaou et al. (2004)
measured signals in MEG from 100 epilepsy surgery candidates ranging from 8-56 years of
age in response to a word recognition task. Single ECDs were used to model the activity and
compute a laterality index. The MEG and IAP lateralisations were concordant to a level of
87%. This study was replicated by Doss et al. (2009) using a cohort of 35 surgery candidates.
The MEG and IAP laterality results were concordant in 86% of cases, with high levels of
sensitivity (80%) and specificity (100%). Breier et al. (2001) performed a similar comparison
of MEG and IAP measures of language laterality in children, demonstrating excellent levels
of concordance in 17 out of 19 patients. Studies such as these were essential in determining
objective criteria with which to improve data quality and the robustness of analysis techniques
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in order to allow MEG to be used for mapping language functions in a clinically relevant
manner.
2.2 Summary
Since its inception, Magnetoencephalography has been used to investigate the underlying
cortical activity related to epilepsy. This began by using MEG as a basic extension of EEG and
simply identifying atypical, epileptiform traces of activity. However, with the introduction
of the equivalent current dipole, the field rapidly moved to performing source modelling in
order to localise the irritative zone. Before MEG was able to be used clinically it required
validation by comparing the results to standard, existing methods. The MEG results were
rigorously compared to those from EEG and intra-operative recordings. As the field of MEG
as a whole began to use the technique to look at the response of specific perceptual and
cognitive systems, the field of epilepsy research continued to develop. Pre-surgical mapping
was performed on primary sensory areas and to derive estimates of language laterality. Again,
at each stage the results from MEG were compared with established techniques such as
electrocorticography recordings and the intra-carotid Amobarbital procedure.
As stated previously, there have been many excellent reviews on the role of MEG in the
localisation of both irritative zones and regions of eloquent cortex (Frye et al., 2009; Simos
et al., 2000). The purpose of the the brief review presented in this chapter is to use the
application of MEG to the diagnosis and treatment of epilepsy as a template with which
to evaluate progress in other clinically relevant areas. The clinical needs prior to surgical
re-section are clearly defined in epilepsy; it is necessary to define the irritative onset zone
and if a cerebral lesion is associated with the seizures, to what extent does this area interact
with regions of eloquent cortex. MEG measurements combined with dipole modelling are
sufficient to be able to provide an answer to these questions in order to allow progression
toward rendering a patient seizure free. However, despite the tools existing to allow MEG to
be used in the pre-surgical evaluation of these patients, the development of newmethods and
techniques did not cease. The next section considersmore recent advances in signal processing
techniques that have been used to further enhance the ability ofMEG to non-invasively inform
the treatment and management of epilepsy. What becomes clear is that the study of epilepsy
via MEG has continued to grow and develop at a similar pace to the development of new
technologies and methods within the broader field. Due to this fact, the speed at which the
scans can be performed has increased as knowledge about the most effective protocols grows.
As confidence in the diagnostic abilities of the technique grows, more and more clinicians
become aware of its utility, resulting in MEG being performed routinely at various epilepsy
centres around the world, not as an an innovative and exploratory technique but as a valued
and essential step in determining the most appropriate intervention (Ray & Bowyer, 2010;
Schwartz et al., 2008). If other conditions are to use MEG as part of a routine diagnostic
procedure, then it is necessary not only to apply standard analysis techniques, but to use
studies of these conditions to drive forward novel and innovative statistical and modelling
techniques.
2.3 Recent epilepsy research
The field of MEG research has continued to grow over the past decade, with new methods,
analyses and statistical approaches being developed and rapidly applied to the investigation
of a vast array of sensory and cognitive systems. The clinically relevant applications of
MEG in epilepsy research were initially developed using the ECD, and this analysis method
for the localisation of the irritative zone and of eloquent cortex has been shown to be
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effective. However, when new techniques were developed, rather than the epilepsy research
persisting with what was already shown towork, researchers embraced these new approaches
and worked to obtain more robust, more accurate localisations of function and a better
understanding of the underlying pathology associated with the illness.
The ECD approach has a number of weaknesses in that it assumes the activity being modelled
is a point-like source of activity. It is also a full inverse solution in that each sensor contributes
equally to the fit. For example, a current source emanating from the frontal lobe will be
best represented on the sensors in the anterior portion of the sensor array. However, the
fields measured on the posterior sensors still contribute to the final fit, and it is possible that
excluding this information from the model would result in a more accurate inverse estimate.
As the activity is treated as a point-like source, there is no estimate of the extent of activation,
or in the case of epilepsy data, the extent of the irritative zone or of eloquent cortex. The two
other commonly used inverse methods are Minimum Norm Estimation (MNE) (Hämäläinen
et al., 1993) and Beamforming (Van Veen et al., 1997). MNE is a distributed source model
which estimates the current density at many thousand locations. The locations are fixed to the
cortical surface and the orientation of the signals are fixed to be tangential to this surface. The
amplitude of these thousands of sources are then estimated from the data. However, MNE
can only be applied in a stable manner to averaged data and, as stated, is restricted to the
cortical surface. Beamforming is an adaptive spatial filtering technique which assesses the
contribution of each voxel within the brain volume to the measured field. Spatial filtering
approaches are now common in research that measures signals via MEG and it is a process
which can be highly flexible. Beamformer solutions are able to perform whole-head analyses
and can also be used to reconstruct the estimated neural time course at any point within the
head. These so-called Virtual Electrodes (VE) have the potential to estimate the electrical
activity of a source at a specific location with the temporal resolution of the original signal.
These more advanced modelling techniques have been used on data from epilepsy patients
and they are potentially able to provide a more satisfactory description of the underlying
pathology than ECD techniques alone. Bowyer et al. (2005) used a current density modelling
approach termed MR-FOCUSS (Bowyer et al., 2005) to estimate cortical regions of language
activation in 27 patients with localised intractable epilepsy. Verb generation and picture
naming tasks were used and a laterality index was calculated for each task and three different
latencies. One latency captured all language processing (150-550 ms) while the other two
focused on activation of Wernicke’s area (230-290 ms) and Broca’s area (396-460). In 23 of
the 24 patients in which a successful IAP measurement was obtained, the laterality of the
activity in the 396-460 ms window was in agreement with the IAP result. Three patients
showed either a bilateral or undetermined language representation on the IAP, and in one of
these patients the lateralisation obtained by the current density estimate was in agreement
with intra-cranial measurements. The results of this study suggest that MNE is able to
provide information regarding the lateralisation of function in a cohort of patients. Give
that the technique estimates neuronal activity at many thousands of cortical locations, and
that laterality is calculated over a number of these estimates, it perhaps allows a more stable
estimate of laterality than using the number of single location, point-like sources from dipolar
models.
Spatial filtering approaches have also been shown to be effective in the localisation of
eloquent cortical function. Beamformers typically focus on the total power of a response
(Hymers et al., 2010), however in recent years there has been an increase in the number
of variations of specific filter implementations. Cheyne et al. (2006) introduced a novel,
event-related beamformer (ERB) based on an implementation initially described by Robinson
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(2004). Cheyne et al. (2007) investigated the ability of an event-related beamformer to
localise somatosensory and auditory cortices in participants withmetallic dental implants and
controls. The ECD model and ERB technique produced comparable localisations in control
participants, but in patients with metallic implants the ECD method was unable to localise
the activity whereas the ERB produced results consistent with expected anatomical regions of
activation. The event-related beamformer has been shown to reliably localise the motor cortex
in paediatric epilepsy patients (Gaetz et al., 2009) and has also been validated against direct
cortical stimulations and the results confirm that it is a viable and robust framework with
which to perform non-invasive preoperatve investigations (Pang et al., 2008). Robinson et al.
(2004) further refined the spatial filtering approach to bias it toward scanning the head for
detection of epileptogenic activity. The electrical time series of activation is estimated at many
thousands of points within the volume and at each location the excess kurtosis is calculated
to give a metric of the “spikiness” of the data. The advantage of these higher level analyses
is that they are more robust to low signal-to-noise ratios and provide a better estimate of the
spatial extent of these regions. The ECD models the activity as a single point-like source,
whereas MNE and beamformer estimates give a greater indication of the extent of activation.
These techniques are also more suited to inferential statistical thresholding than the ECD.
The MNE and, in particular, beamformer analyses are tools which can be implemented in a
number of different ways in order to optimise the analysis to focus on the specific response
of interest. When investigating complex and dynamic processes such as language processing
and higher cognitive mechanisms, these are highly desirable facets of an analysis. It is likely
that the application of MEG to clinical populations other than epileptics will be dependent on
the power and flexibility of these techniques being fully exploited.
The MEG community now also benefits from time and the fact that it is no longer a new
technique with a relatively small amount of expertise and knowledge within the field. In
recent years there has been a rapid increase in the amount of theoretical and methodological
work in order to really push the boundaries of what types of analyses are possible with MEG
data. The purpose of this section is to outline how these recent advances have already been
applied to the study of epilepsy and how the proliferation of novel and specific analysis
techniques means the potential of MEG to be used in a wide range of clinical setting becomes
very real.
Previously, one logistical downside of MEG was the amount of data acquired, with modern
scanners having in excess of 200 sensors and a default sampling frequency of around 600 Hz,
the amount of data collected in a single study can be vast. However, with modern computing
power now more affordable and more efficient, there are many fewer constraints on the type
of analyses it is possible to perform. The fact that data storage and transfer is now much
easier to implement and manage allows even more data to be collected. It is therefore now
possible to collect data at much higher sampling frequencies and these large datasets can still
be manipulatedwith ease. One area in which there is unexplored potential is in the acquisition
of MEG signals in the upper parts of the frequency spectrum. Typically MEG signals are
acquired at 300-600 Hz, and for many studies which investigate human neural processes the
analyses focus on biological signals below 100 Hz. Recent work however has shown that there
may be reliable diagnostic information represented in high frequency oscillations produced
by epileptogenic cortex. The presence of fast oscillations, or ripples, at 100-250 Hz and also
fast ripples between 250-500 Hz has been demonstrated in depth electrode recordings made
from patients suffering from epilepsy (Bragin et al., 1999; 2002). Urrestarazu et al. (2006)
investigated high-frequency activity that occurred during the slow wave immediately after
an inter-ictal event and found that in patients suffering from epilepsy there was a decrease
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in the energy content at frequencies above 100 Hz. Further work demonstrated that ripples
were seen in all epilepsy patients in a group of seven and fast ripples were found in five
of these patients (Urrestarazu et al., 2007). Furthermore, there was a higher incidence of
ripples measured from inside the irritative zone compared to outside it and this effect was
even stronger for the incidence of fast ripples. Therefore the existence of high-frequency
oscillations could be used to delineate the irritative zone and epileptogenic zone from other
regions of cortex.
High frequency oscillations have been detected in MEG and these signals are potentially a
more accurate and robust indication of the extent of the epileptogenic zone. Xiang et al.
(2009) collected MEG signals at a sampling frequency of 4 kHz from 30 paediatric epilepsy
patients. 86% of patients showed high frequency oscillations and 63% showed more than
one high frequency component. The range of frequencies varied across patients with a peak
of 910 Hz. Localisation of this high-frequency activity was performed with a beamformer
and the sites of activation identified were concordant with cerebral lesions in 70% of cases.
Eleven of these patients went on to have surgery and the MEG localisations were concordant
with intra-operative recordings in 82% of patients. The combination of high frequency data
with a spatial filtering approach is therefore potentially more reliable than standard dipolar
techniques in the pre-surgical evaluation of epilepsy patients (Xiang et al., 2010). Although
there is still much validation work to be done, for example it may be desirable to combine
high frequency data with the excess kurtosis beamformer, it is clear that the clinical efficacy of
MEG regarding the treatment of epilepsy continues to develop and evolve.
3. Parkinsonism research
Parkinson’s disease is a degenerative disorder of the central nervous system with symptoms
typically including tremor, rigidity, slowness of movement and postural instability. The
current pathophysiological concept of Parkinsonism is that due to a loss of dopaminergic
connections from the substantia nigra to the striatum there is abnormal functionality in the
basal ganglia (Obeso et al., 2000). This hyperactivity in the subthalamic nucleus leads to
inhibition of the thalamus and subsequently the sensorimotor cortex which leads to a loss of
bodily movement, known clinically as hypokinesia. This altered connectivity affects the entire
motor network, and evidence for the concept was found when high frequency stimulation of
the subthalamic nucleus caused a reduction in Parkinsonian symptoms (Krack et al., 1998).
As Parkinson’s disease is the manifestation of altered connectivity, which causes a change in
oscillatory dynamics in cortical areas, it is potentially well-suited to study and detection via
MEG. This section aims to outline the advances made, and analyses used in the application
of MEG to the identification of this disease. Specific studies are highlighted to show the
progression and development within the field (see for example Berendse & Stam, 2007; Stam,
2010; Timmermann et al., 2007, for a more exhaustive review of the literature).
Volkmann et al. (1996) provide one of the earliest studies using MEG to investigate
Parkinsonian tremor. As with much of the early epilepsy research, a single ECD model was
used to localise activity. The data analysis was biased to focus on oscillatory activations
that were concurrent with the observed Parkinsonian tremor. The dipole models showed
activity at the diencephalic level and in pre-motor and sensorimotor cortices accompanied
the resting tremor. Since it became clear the MEG could be used to investigate the underlying
pathology associated with Parkinson’s disease there have been a number of follow-up studies.
Although the volume of studies is far fewer for Parkinson’s disease than for epilepsy, a similar
pattern can be seen in the types of studies performed and the progression in complexity of
analysis approaches. As was described earlier in the context of epilepsy diagnosis, more
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recent investigations of Parkinson’s disease using MEG have utilised more specific analysis
techniques which are more suitable to studying the disease than the simple ECD.
Many of the analysis methods used focus on characterising the oscillatory dynamics
associated with Parkinson’s disease at the level of the sensors rather than performing source
modelling. Kotini et al. (2005) measured spontaneous MEG signals from 9 Parkinsonian
patients with minimal tremor. Each recording was 2 minutes in duration and the eyes
remained closed in order to reduce artefacts and increase the alpha rhythm. The power
spectrum for each each sensor was calculated by means of a Fast Fourier Transform (FFT)
and the first dominant frequency was extracted. In a comparison of controls versus patients,
the patients showed a prominent frequency which was lower than the 6 Hz typically observed
in the healthy controls. The spatial distribution of power in these patients tended to be over a
wide region in the low-frequencies whilst healthy controls showed a more focal topography
for their higher frequency predominant activity. Bosboom et al. (2006) used similar techniques
to investigate oscillatory differences between demented and non-demented Parkinsonian
patients. Spontaneous neuronal signals were measured via MEG from 13 demented and
13 non-demented patients whilst off medication. Two 13-second epochs were used for data
analysis and the data filtered in to delta, theta, alpha, beta and gamma bands of activity.
The MEG sensors were also grouped into regions of interest i.e. frontal, central, parietal
and occipital on both side of the sensor array. Non-demented patients showed a diffuse
increase in theta power and a decrease in beta power relative to controls in central and parietal
channels. Demented Parkinson’s disease sufferers showed a diffuse increase in delta and theta
power and a simultaneous decrease in relative alpha and beta bands when compared to the
non-demented controls. Stoffers et al. (2007) used the same technique to show that the slowing
of oscillatory dynamics is a feature of non-demented Parkinson’s patients from a very early
stage in the disease and this is independent of disease duration, severity and dopaminergic
treatment. Stoffers et al. (2008) also investigated differences between patients in the early and
later stages of the disease. In this study, the same frequency bands and sensor topographywas
used but instead of calculating changes in total power, or changes in relative power between
two populations of patients, synchronisation likelihood (SL) was calculated. SL is used to
to estimate both linear and non-linear correlations between time-series. SL was calculated
both within and between specific topographic regions within the sensor array. The results
showed that early-onset, drug naive patients showed an increase in SL in the 8-10 Hz band
relative to controls whilst disease duration was positively related to 10-13 and 13-30 Hz. The
8-10 Hzwas therefore thought to represent increased resting-state cortico-cortical connectivity
from the onset of the disease and this altered connectivity extends to neighbouring frequency
regions as the disease progresses.
It is highly encouraging that differences between patients suffering from Parkinson’s disease
and healthy controls can be observed at the level of the sensors. Furthermore, differences
between demented and non-demented, early and late onset sufferers can also be detected.
These studies suggest that the underlying pathology of the disease may have specific
representations in certain frequency bands and in specific parts of the sensor array. The clinical
utility of these observations is that MEG could be used to obtain an objective measure of the
specific nature of Parkinson’s disease and also when diagnosed, the technique may be used
to provide an estimate as to the duration of the disease and to provide a measure of the rate
of decline. Although it is encouraging that differences can be seen at the sensor level in a
population of Parkinsonian patients, the analyses in some cases are highly rudimentary. It
may be that specific types of Parkinson’s disease can be identified via the oscillatory activity
measured at the MEG sensors without any inverse modelling, and that this framework can
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be extended to other neurodegenerative disease. It is not the case that the more complex and
mathematically intricate an analysis is the more accurate or robust it becomes, and therefore
constraining analyses to the sensor domain may be entirely appropriate in some cases and
extremely effective. However the method of peak-picking in the spectral domain is highly
simplistic as well as being statistically weak. For example it is unclear if this type of activity
is associated with other illnesses, or how prevalent such activity is the normal population.
The use of synchronisation likelihood is a more powerful technique, but it is still limited
to the analysis of data on the sensors. Parkinson’s disease is thought to manifest as the
altered connectivity between cortico-cortical connections and thus what the MEG is able to
measure is how these changes in connectivity affect the global brain dynamics. There are
a number of problems associated with performing connectivity analyses at the level of the
sensors, and these issues all essentially stem from the issue of field spread. Due to the fact
that a neuronal source is measured by a number of sensors it is possible to observe long-range
interdependencies between MEG sensors and any change seen in the specific connectivity
measure chosen could be due to a number of reasons (Schoffelen & Gross, 2009). Therefore,
although the initial results are promising in that differences between clinical populations can
be observed, the techniques and analyses require more robust validation. One method for
mitigating the effect of field spread to some degree is to perform the analyses in source space
rather than sensor space. As discussed earlier, the spatial filtering framework is a flexible
approach which can be tailored to focus on specific responses, and even with the relatively
small number of studies on Parkinson’s disease patients, at least compared to epilepsy studies,
already the field has start driving forward innovative and specific analysis approaches.
Gross et al. (2001) introduced a specific beamformer implementation to focus on
cortico-cortical connectivity. The Dynamic Imaging of Coherent Sources (DICS) approach
is a frequency-domain spatial filter implementation that allows coherence to be estimated
throughout the brain volume. Each location within the brain is compared to a reference
measure of coherence, which can be taken from an external source such as an electromyogram
(EMG) or from a specific region of interest within the brain volume. In a single patient
suffering from idiopathic Parkinson’s disease, spontaneous activity was recorded for 5
minutes in conjunction with an EMG. Cortico-muscular coherence was estimated in the 9-12
Hz frequency band as this range contained the largest component in the power spectrum of
the EMG. The resultant volumetric image showed peak levels of coherence in the contralateral
primary motor cortex. This approach was shown to be more robust than using signals
recorded on the sensors. Timmermann et al. (2003) extended this case study example to a
cohort of 6 individuals suffering from tremor-dominant Parkinson’s disease in order to better
characterise the oscillatory network involved in Parkinson’s disease. When off medication
patients showed a dominant 4-6 Hz tremor which cohered strongly with the EMG. The
main frequency of cerebro-cerebral coherence was at double this tremor frequency. Thalamic
and cerebellum activity showed a broad peak of coherence around 20 Hz. They reported
a bi-directional coupling between the EMG and cortical areas such as the posterior parietal
cortex and secondary somatosensory cortex.
Litvak et al. (2010) used a spatial filter analysis to analyse MEG recordings from patients
with electrodes inserted into the subthalamic nucleus to allow deep brain stimulation of
the structure. Such a procedure can be used to treat Parkinson’s disease by electrically
stimulating the subcortical structure in an attempt to realign the oscillatory dynamics
of the cortico-cortical loop. In many ways this is analogous to the comparison of
electrocorticography recordings in epilepsy patients and ascertaining to what extent the MEG
can be an accurate and reliable measure of the underlying neuronal activity. The inserted
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electrode not only has the ability to deliver a current to the area, but to also record signals.
MEG data were acquired from a single Parkinsonian patient and a healthy control whilst
at rest and also whilst performing a simple, and then a more complex motor task. An
electro-oculargram and EMG were acquired simultaneously. The inherent noise-cancelling
effect of a beamformer was used to localise source activity despite the large signals produced
by the implanted electrodes and associated hardware. The DICS beamformer was used to
localise cortical sources that were coherent with signals in the subthalamic nucleus detected by
the inserted electrode, to estimate the time course of cortical activity using a virtual electrode
and to uncover volumetric regions associated with movement-related power changes. Litvak
et al. (2011) extended this use of the DICS beamformer into a larger cohort of 13 Parkinson’s
disease patients with a view to describing the dynamics of the cortico-subthalamic loop
rather than focusing on methodology. Two different networks were identified which were
distinct both in spectral power and spatial location. A temporoparietal-brainstem network
was coherent with recordings from the subthalamic nucleus in the 7-13 Hz frequency range,
whilst a frontal network was coherent with subthalamic recordings in the 15-35 Hz range. It
was also noted that dopamine levels increased the coherence of this frontal network. It is
possible that these networks represent distinct manifestations of the disease and if they can
be better characterised may lead to a more successful diagnosis of the different Parkinsonian
subtypes to ensure that patients receive the correct treatment at the earliest possible stage in
the disease onset.
The other potential clinical utility of MEG in the diagnosis and treatment of Parkinson’s
disease is to quantify the affects that external cortical stimulation has on a patients symptoms.
Mally & Stone (1999) describe a study in which the application of transcranial magnetic
stimulation (TMS) was shown to alleviate Parkinsonian symptoms in a group of 10 patients.
TMS is a technique whereby a focused, high-amplitude magnetic field is produced by a coil
positioned outside the head which induces electrical activity within the brain. The therapeutic
effects of TMS and direct current stimulation (a techniquewhich also induces electrical activity
within the brain) have been demonstrated to be long-lasting (Lefaucheur et al., 2004; Wu et al.,
2008). However, it can clearly be seen in a systematic review of the literature by Fregni
et al. (2005) that the mechanisms by which symptoms are alleviated as well as the optimal
parameters of stimulation duration, frequency etc are unknown. MEG has been used to try
and uncover the reasons why techniques such as TMS are able to alleviate symptoms. If
this can be uncovered then it would greatly enhance the efficacy of this intervention and
also allow it to become more commonly used. Anninos et al. (2007) recorded one minute of
MEG data from 30 patients diagnosed with idiopathic Parkinson’s disease both before and
after the application of TMS. Patients were divided into two group of partial responders
and favourable responders. Partial responders were patients whose tremor or dyskinesia
returned within 12 months and showed a low-amplitude alpha rhythm in their subsequent
EEG. Favourable responders showed no Parkinsonian symptoms for a year and showed
a high-amplitude alpha rhythm. The only MEG analysis performed in this study was to
label the pre and post stimulation recording as one of normal, abnormal or partially normal.
Therefore the analysis allows no insight into how the intervention alters the cortico-cortical
network in order to alleviate symptoms. A more systematic study could use MEG to quantify
the oscillatory dynamics of the network before and after TMS is applied with a number of
different sub-groups, each one receiving a different set of parameters. In such a study MEG
may be able to provide a clear insight as to why the TMS has such a profound benefit, and
then efforts can be focused on optimising the magnitude and duration of any alleviation from
symptoms.
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3.1 Summary
Numerous studies have provided evidence for the fact that MEG is able to measure oscillatory
dynamics related to Parkinson’s disease at the levels of the sensors. Differences have been seen
not only between recordings from patients and healthy controls but also between different
phenotypes of the disease. Further validatory studies are needed to build on the evidence
for the ability of MEG to to accurately observe the effects of altered connectivity between
subcortical and cortical structures. However, the initial work is promising and suggests that
the technique may well have a role to play in improving diagnosis of the disease, monitoring
specific interventions and evaluation of the effect of specific pharmacological treatments.
MEG can potentially provide an objective means by which to determine the specific type
of Parkinson’s disease, which may lead to the most effective treatment being administered
quickly. The techniquemay also be able to be of predictive value in determining the likelihood
of severe and rapid dementia being co-morbid with the disease. The progression of analysis
techniques in many ways matches that of epilepsy research, with initial studies using the ECD
before more specific analysis tools were adopted that are more appropriate to the response of
interest, such as a spatial filter that is sensitive to coherence. Spontaneous recordings are often
made, but movement tasks are also used as it is known that the motor network is involved
in the disease. As the range of statistical analyses grow and are developed with the specific
goal of characterising cortico-cortical loops, the clinical application of MEG to populations of
Parkinsonian patients in a routine and systematic way is likely to move from possessing great
potential to a real possibility.
4. Alzheimer’s disease
Alzheimer’s disease is the most common neurodegenerative disease and detecting
individuals who are susceptible to the condition and achieving an accurate and early
diagnosis is an essential step in developing and quantifying effective therapies. As with
previous sections, the aim is to not to provide an exhaustive review of the literature to date
(for such a review see Criado et al., 2006), but to give an overview of the progress made
in the uses of MEG to investigate Alzheimer’s disease. Berendse et al. (2000) provided an
initial description of the oscillatory changes involved in Alzheimer’s disease by measuring
the resting-state MEG from a group of 5 patients and 5 age-matched controls. Power and
coherence were calculated in a number of frequency bands and the patients showed a greater
magnitude and diffusion of low-frequency signals, predominantly in the frontal regions.
Higher frequency power was decreased in patients over temporal and occipital regions. In
patients, the coherence values at all frequencies were found to be lower than in controls. which
suggests that there may be readily available metrics with which to quantify the extent of the
condition. Fernández et al. (2006) extended this into a more thorough analysis of the spectral
content of MEG data acquired fromAlzheimer’s patients and reported that oscillatory activity
in the 2-4 Hz and 16-28 Hz ranges showed high degrees of sensitivity and specificity when
classifying data as from a patient or a control. Whenmeasuring signals from patients suffering
from Alzheimer’s disease, it is common to not only acquire resting-state oscillatory changes,
but also those involved in a task. For example Pekkonen et al. (1996) noted that in patients, the
auditory response to simple tones was delayed when compared to age-matched controls. The
P50 and N100 are standard responses that occur originate from primary auditory cortices in
response to tones with simple pitch and amplitude characteristics. The study demonstrated
that if the sound was played to a single ear, these early sensory responses were delayed in
the ipsilateral but not contralateral hemisphere of patients. Pekkonen et al. (2001) extend this
finding to look at the process of performing auditory discriminations, i.e. a task with some
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decision process and active listening rather than looking at passive, automated responses. The
results confirmed that ipsilateral auditory areas showed a delayed response, although this
did not affect the patients’ ability to perform the auditory discrimination task. These findings
suggest that it may be possible to use abnormal processing in sensory systems to perform
an objective assessment of Alzheimer’s disease and that these changes need not necessarily
be associated with impaired cognitive or sensory percepts. Of course the difficulty is then to
determine whether delayed auditory processing points to the onset of Alzheimer’s disease or
the onset of some other condition.
Another task which is used to investigate cortical dynamics in Alzheimer’s disease is a
memory task, which is concordant with one of the prominent features of the disease being
impaired memory. Maestú et al. (2001) used a high load probe task in which targets needed to
be remembered and distinguished from distractors. Control subjects were reported to show an
increased number of sources over temporal and parietal regions 400-700 ms after the stimulus
onset, whereas Alzheimer’s patients showed a greater number of sources over frontal motor
areas. The number of sources in patients’ left parietal regions was also predictive of their
performance on clinical scales of cognitive functioning. In a second study, these left parietal
sources were also found to be correlated with the level of hippocampal atrophy (Maestú et al.,
2003). One of the potential clinical applications of MEG in the diagnosis and treatment of
Alzheimer’s disease is to be able to predict which individuals are susceptible to the disease
and how rapid their decline may be. Alzheimer’s disease has a long pre-clinical stage and
Mild Cognitive Impairment (MCI) is often used to describe individuals who are declining
from normal cognitive function to dementia. There is a conversion rate of MCI to Alzheimer’s
disease of around 10-15% per year (see Shah et al., 2000, for a review). Fernández et al. (2006)
assessed the ability of MEG to determine the risk factor associated with individuals with
MCI developing Alzheimer’s disease. Dipoles were fitted to the low-frequency regions of
the spectrum of resting-state recordings. Dipole density in the left parietal regions fitted over
the delta frequency band were found to provide a reliable classification of Alzheimer’s and
MCI patients. MCI patients were also categorised as being at either low or high risk based on
the observed magnetic fields. A follow-up clinical examination occurred 2 years later and the
fact that more patients in the high MCI group had developed Alzheimer’s disease than the
low MCI group suggests that MEG can be a useful clinical utility for identifying risk factors
for individuals. Osipova et al. (2006) conducted a study with a similar goal of predicting
transition from MCI to Alzheimer’s disease, and reported that the source distribution of the
alpha rhythm was abnormal in Alzheimer’s patients but not MCI patients when compared to
controls, and so the changes in neuronal processes associated with MCI may be more subtle
and more complex than those associated with other neurodegenerative diseases. Of course
more longitudinal studies are required and, like other techniques discussed in this chapter, it
may be desirable to move away from a simple dipolar technique and investigate the dynamics
using other methods, but the initial results are promising.
Spatial filtering approaches have also been applied to Alzheimer’s disease data which, as
previously discussed, offers a more complete description of the data as it treats the activity as
a distributed network rather than point-like bursts of activity. Alzheimer’s, MCI and control
patients were scanned and the two patient groups were noted not to show any slow-wave
MEG activity in conjunction with the task, which was simply closing the eyes and opening
them at 10 second intervals. The beamformer analyses revealed all three groups had increased
activity in posterior regions when the eyes were closed in the 8-15 Hz band. Patients suffering
from Alzheimer’s disease showed greater activity in frontal regions in this frequency band
when the eyes were closed compared to controls, whereas MCI patients showed no such
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difference. This finding was taken to show that alpha activity is found in frontal regions for
Alzheimer’s patients across a cohort, whereas the same is not true forMCI patients or controls.
These findings, both in the spectral frequencies involved and the volumetric locations are
consistent with previous results. Further analyses also confirmed that these changes in activity
were correlated with clinical examinations of the mental state of the Alzheimer’s disease
patients (Ishii et al., 2010).
Dipolar and beamformer approaches have been shown to provide an objective measure which
can categorise an individual as suffering from Alzheimer’s disease. Such a technique could
be valuable in the treatment of a disease that is difficult to diagnose and categorise. However,
as the disease affects cognitive function in a general way, and in a manner that is only broadly
consistent across individuals, applying these analyses to resting-state data may not be the
best use of the technique. A number of higher-level techniques have been applied to MEG
data acquired from Alzheimer’s disease patients. Poza et al. (2008) used techniques from
information theory to discriminate the resting-state data from a group of individuals and
age-matched controls. Power spectral densities were calculated from the data and three
different methods were used to compute the spectral entropy of the signals. Entropy can
be thought of as a measure of uncertainty and it was demonstrated that Alzheimer’s patients
showed significantly lower levels of entropy than control participants. On the basis of these
entropymeasures, data from individuals were accurately identified as from patient or controls
to a level of 87% and suggest a loss of irregularity in the dynamics of Alzheimer’s patients. A
similar finding, that data from Alzheimer’s patients is more regular than that from controls,
was reported using approximate entropy (Gomez et al., 2010). It is therefore possible that
higher level statistical analyses may be more robust to detecting the signature oscillatory
characteristics of Alzheimer’s disease. It is these types of innovative, robust approaches
that, when developed with specific clinically relevant questions in mind can allow MEG to
be applied reliably to groups of patients suffering from illness and disease. Although much
more is needed, both in terms of basic research and clinical trials in the efficacy of MEG in the
identification and monitoring of neurodegenerative disease, the clinical applications are clear
and the benefits are potentially vast.
5. Future applications
Specific diseases have a well defined biomagnetic representation. For example epileptogenic
activity is typically high amplitude and can be characterised as slow wave activity or
“spike-and-wave” activity. It has a strong dipolar representation on the sensors and is
therefore readily identified both visually and statistically. Other types of illness such as
Parkinson’s disease show more complex temporal dynamics in the measured MEG, however
there are still typical spectral shapes which can be used to identify the illness, for example
diffuse and exaggerated low-frequency information. Parkinson’s disease is also known to
affect connectivity related to motor cortices and so there is a priori information regarding
sensors and cortical regions of interest. There are however, numerous diseases which do
not have such clearly defined neuromagnetic representations. However, some of these
illnesses are still suitable to diagnosis and detection via MEG. Detection of certain illnesses
is possible via a neural system largely unrelated to the symptomatic manifestation of the
disease. “Biomarker” is a term often used to describe the observation of altered or atypical
processing in one domain which provides an independent measure of another function, in
this case an objective measure related to an illness or disease. Such a measure may allow
early and effective diagnosis, to evaluate different interventions or to predict an individuals
responsiveness to a drug or their rate of decline. This final section gives a brief overview
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of some of the recent applications of MEG in the identification of biomkarkers for specific
conditions.
The application of MEG measurements to patient populations is clearly still developing and
evolving. One of the biggest risk factors in developing neurodegenerative disorders is age
and although, as previously discussed, MEG is able to provide a measure of the underlying
neuronal activity associated with these diseases, the changes in oscillatory dynamics in the
normal aging population are still poorly understood. Rossini et al. (2007) note that MEG
can be used in conjunction with other imaging modalities in order to distinguish between
physiological and pathological aging. In order to more robustly identify neurodegenerative
disease it is essential that the aging brain is more fully characterised. This needs to be done not
purely in terms of the dominant spectral frequencies of the data, but also using higher-level
metrics such as coherence, entropy etc. The statistical robustness of diagnosing diseases such
as Parkinson’s and Alzheimer’s will then increase as the distribution of the normal population
can be characterised and these conditions may be more clearly identified.
MEG has been used to investigate responses associated with schizophrenia and
schizoaffective disorder. Uhlhaas et al. (2008) provide a review of the role of oscillatory
rhythms in cortical networks in relation to the illness. The role of delta, theta, alpha, beta
and gamma rhythms are often discussed in relation to a range of neural processes such as
memory, language, auditory and visual processing. The synchrony and amplitude of these
rhythms during a range of behavioural tests are seen to be altered in patients suffering from
Schizophrenia, and so investigation of these processes via MEG may provide an insight
into the development and manifestation of the disease. More specific examples include
altered auditory processing in response to deviant sounds. The Mismatch Negativity (MMN)
paradigm is often used to investigate automatic auditory processing. A sequence of identical
stimuli are played and a deviant stimulus is inserted at random. For example, in the
middle of a train of 500 Hz tones, a 550 Hz tone is heard. The response to this deviant is
amplified and an insight into the auditory system can be obtained. Näätänen & Kähkönen
(2009) describe data which demonstrates that in schizophrenic individuals the MMN is
attenuated. The MMN in response to frequency deviation is also found to be attenuated in
a manner that reflects the progress of the disease as measured by disease duration. There
is also evidence that specific characteristics of the MEG measured in response to auditory
stimulation may implicate the patients possessing positive or negative symptoms. Reite et al.
(2010) retrospectively investigated differences between the auditory steady-state response
of patients with schizoaffective disorder and schizophrenia and suggest that whereas the
amplitude and phase of the response is atypical in schizophrenia sufferers, the schizoaffective
disorder patients are more similar to controls. Differentiating between schizophrenia and
schizoaffective disorder is a difficult and unclear process, however differential diagnoses
lead to different interventions and different paths of pharmacological treatment. Therefore
the potential ability of MEG to differentiate between the two could have great clinical
utility. Ince et al. (2008) used a working memory task and demonstrated differences between
schizophrenic patients and controls in specific parts of the sensor array and in specific
frequency bands.
Autism spectrum disorder (ASD) is another condition that has received interest from
researchers who use MEG as a measure of neuronal functioning. ASD encompasses a number
of illnesses including Autism disorder and Asperger’s syndrome. The conditions are most
commonly diagnosed in childhood and therefore early detection may be able to limit the
impact they have on development into adulthood. Again, the auditory system appears to be
reliably associated with the underlying nature of the conditions, with ASD patients showing
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both delayed and attenuated responses to simple sounds when compared to age-matched
controls. Roberts et al. (2010) presented tones of different frequencies to a group of ASD and
healthy controls and analysed the M50 and M100 response from both left and right superior
temporal gyri. No differences were seen between groups for the amplitude or latency of the
M50 but the M100 response was delayed in ASD patients by an average of 11 ms across the
entire group. One clear difference between ASD and the other conditions discussed in this
chapter is that ASD is a neurodevelopmental disorder, and therefore by its very definition
affects the paediatric population. This therefore amplfies some of the inherent challenges of
scanning patients in MEG, such as movement of the head and trunk and also stresses the
need to design protocols that can be easily understood and tolerated by young individuals.
Scanning children in MEG is a time consuming and difficult process, and the data are more
susceptible to artefacts. However, given the prevalence of ASD, the potential benefits of using
MEG as a screening tool to allow early identification of the illness make the technique a
valuable one.
Georgopoulos et al. (2007) made MEG recordings from 142 individuals whilst they fixated
on a spot of light for 45-60 seconds. The analysis stream utilised the sensor information
and assessed zero-lag cross-correlations in order to provide an estimate of synchronous
coupling. The analyses appear to provide some insight regarding which subset of clinical
conditions each participant could be categorised as matching. Patients with multiple sclerosis,
Alzheimer’s disease, schizophrenia, Sjogren’s syndrome, alcoholism, and facial pain as well
as a group of control participants were reliably identified. A second study by the same
group applied similar techniques to a group of patients suffering from post-traumatic stress
disorder (Georgopoulos et al., 2010). Although a study which attempts to differentiate so
many different conditions is susceptible to limitations in the analysis and a lack of statistical
robustness, the results are extremely promising and highlight the powerful nature of MEG as
a non-invasive tool with which to objectively evaluate clinical populations.
MEG has also been found to have a clinical utility unrelated to measures of functional
mechanisms. Martino et al. (2011) used MEG to look at the functional connectivity of the
so called “resting-state network”. The resting-state network is used to describe the cortical
dynamics that can be observed in the absence of any task. Functionally connected regions
still communicate with each other and decreased levels of connectivity in this network
are expected in many types of illness and disease. Functional connectivity is an umbrella
term used to describe a series of analysis methods which focus on measures of coherence,
correlation and synchronisation. A brief overview of some of these metrics has been given in
previous sections of this chapter, however it is worth noting that measures of connectivity
are becoming more and more sought after by researchers of human brain function. The
advantage of studying the resting-state connectivity of areas is that no task is required,
which means the recodring can be short and can be carried out in patients who may
struggle to perform a language, memory, or movement task. Martino et al. (2011) created
functional connectivity maps using imaginary coherence and the aim was to determine if this
information could predict the results of intra-operative electrical stimulation (IES) carried
out to identify eloquent regions of cortex. 57 patients with tumours in or near motor,
sesnory or language areas were studied. A lesion-related area of cortex was identified and
compared to a representative number of points taken from the whole of the brain, as a
control the lesion-related area was compared to the same area in the contralateral hemisphere.
The results revealed MEG functional connectivity maps to have a 100% negative predictive
value, which means that when the connectivity in the lesion-related area was lower than the
contralateral volume in each of these patients (a total of 7), no functional areas were idenitied
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in the lesion via IES. In 42 subjects, at least some voxels in the lesion-related area showed
increased connectivity and in 64% of these patients, IES revealed a functionally active area.
The authors stress that the study must be repeated on a larger sample of patients but, as
they also note, the potential clinical utility of such information has a potentially huge impact
upon pre-surgical planning and investigation. These recordings are very short and require no
active participation in a task, or any attentional processes. The study presented attempts to
use robust statisatical analyses to evaluate the responses, a facet which is missing from MEG
studies in a number of areas. The resting-state network, also known as the default-mode
network, has become a hot topic in both fMRI and MEG in recent years.
Currently, a large number of metrics are used to obtain an estimate of so-called functional
connectivity. Methods such as coherence, imaginary coherence, phase lag index and
synchronisation likelihood are currently being applied to MEG recordings from both patients
populations and healthy controls. Although they differ in their underlying mathematics, their
specific assumptions are the same, that distant brain regions that are communicating with
each other will have an observable MEG signal which is very similar. The main problem
for all the methods is also the same, that of field spread. This results from the fact that
any inverse estimate is calculated using only the sensor data, and this information is the
same when estimating activity coming from region A and region B. Therefore spurious
connectivity becomes highly likely given that the same sensor data is used to obtain both
inverse estimates. It is likely that in the coming years a number of these methods will emerge
as being favoured. This must be because they are 1) the most robust to spurious connectivity
and 2) they are suitable for statistical interrogation. If the application and devlopement
of these connectivity measures can be done in clinical populations in parallel with healthy
controls then the resting-state network, and estimates of the connectivity present within the
network, has the potential to be a clinically relevant tool which is not limited to a specific
sub-type of illness. Such a measure could be used a a preliminary screening tool for a range of
conditions, however if the clinical utility of such an approach is to be maximised, it is essential
to fully characterise the network in the normal population and then develop statistically viable
ways of identifying how different diseases affect the network.
6. General summary
This chapter has outlined the current clinical utility of MEG by charting the progression of
analyses and methodologies in a range of different clinical populations. What is striking is
the similarity which exists in the progression of the technique across different sub-types of
illness and disease, despite the fact that these advances were made at very different moments
in time. Epilepsy is by far still the area which is able to obtain the most clinically relevant
information from MEG scans. The initial role of MEG in epilepsy diagnosis and management
was to identify atypical waveforms, much in the same way as EEG was used. This was then
followed by the use of dipole fitting techniques to estimate the brain location responsible
for the epileptogenic activity. Dipolar techniques were then applied to various perceptual
and cognitive functions in the epileptic population to delineate eloquent cortex before more
advanced modelling techniqes such as minimum-norm estimation and spatial filters were
used to better characterise the dynamic changes in neuronal activity. These advances took
somewhere in the region of two decades, as the field of epilepsy research via MEG managed
to maintain pace with the general field of MEG research. Subsequently, MEG has been used
to investigate the underlying dynamics of a range of illness and disease, and although the
developments have occurred at a greater pace, the general pattern persists; dipole fits are
first applied to passive resting data, they are then applied to more complex perceptual and
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cognitive tasks before more complex modelling criteria are used altogether. MEG has been
shown to be able to reliably distinguish the length of onset of a disease, to accurately identify
an individual as being a patient or a healthy control, and to predict the probability of a patient
suffering further decline. The type of illness and disease that these effects have been shown for
are typically difficult to detect clinically until relatively late in the progression of the disease.
Therefore the early, accurate and reliable diagnosis of these conditions can allow patients to
receive the appropriate intervention as soon as possible.
The methodological advances in MEG now occur at a rapid pace, with ever more eloquent
and complex measures of coherence and correlation applied to investigate mechanisms of
functional connectivity. Many of these measures have been shown, in small samples, to
have a potential clinical utility. Due to MEG now being more widely used and better
understood than in the early days of epilepsy research the field is in an extremely promising
position. Much work is needed over the coming years to validate these initial clinical findings.
Independent clinical tests are needed to support the information obtained via non-invasive
biomagnetic measurements. Longitudinal studies are required to determine the accuracy
and sensitivity with which MEG is able to predict the onset and development of certain
conditions. Comprehensive and thorough research studies are needed to determine the most
robust algorithmswithwhich tomeasure coherence between different brain regions, and there
needs to be clear bi-directional communication between scientists and clinicians to establish
what the clinically relevant questions are and if MEG is technique which is able to add extra
information to the diagnosis of a range of conditions. There is no doubt that the evidence for
the clinical utility of MEG is compelling, It is no longer a technique reserved for identifying
epileptiform activity, it is now a technique with the potential to provide an insight into the
underlying neuronal activity of pathologies which currently no other invasive or non-invasive
method can. There is much confirmatory work to be done but, MEG clearly does have the
potential to become a routinely used method to aid in the diagnosis and treatment plan of a
range of diseases which manifest themselves as cerebral deficits.
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